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The life cycle of an intestinal epithelial cell is terminated by apoptosis and/or cell shedding. Apoptotic deletion of epithelial cells
fromtheintactintestinalmucosaisnotaccompaniedbydetectableinﬂammatoryresponseorlossofbarrierfunction.Butincreased
permeability of the epithelial barrier and increased apoptotic rates of epithelial cells have been reported for patients suﬀering
from inﬂammatory bowel disease. Microbiota can both induce or inhibit apoptosis of intestinal epithelial cells thus contribute to
mucosal inﬂammation or support epithelial integrity respectively. Bacteria-mediated cytokine secretion and altered cell signalling
arecentraltoepithelialinjury.Tumornecrosisfactor(TNF)secretedafterexposuretoinvasivebacteriainducesbothapoptosisand
cell shedding. TNF is the major target gene of the transcription factor nuclear factor-kappa B with both pro- and anti-apoptotic
eﬀects. Autophagy promotes both cell survival and “autophagic” cell death. If autophagy is directed against microbes it is termed
xenophagy. Inhibition of xenophagy has been shown to decrease cell survival. Endoplasmic reticulum (ER) stress causes misfolded
proteins to accumulate in the ER lumen. It was suggested that ER stress and autophagy may interact within intestinal epithelial
cells. Apoptosis in response to infection may be well proposed by the host to delete infected epithelial cells or could be a strategy
of microbial pathogens to escape from exhausted cells to invade deeper mucosal layers for a prolonged bacterial colonization.
1.Introduction
The ﬁrst boundary between self and nonself is constituted
by intestinal epithelial cells. The intestinal mucosa forms a
primary phalanx providing both barrier function and imme-
diate eﬀective recognition of bacterial products invading the
mucosa. This is of great importance for the prevention of
permanent and chronic inﬂammation as a reaction to the
commensal intestinal ﬂora and the multitude of antigens
present in the intestinal lumen. Due to its enormous surface
area, the barrier function of the intestinal mucosa may
be as important as its function in nutrient absorption
[1].
Intestinal epithelial cells are generated from stem cells at
the lower third of the crypt and reach the intestinal lumen in
3–5 days. Apoptosis is initiated and cells ﬁnally lose anchor-
age and are shed into the lumen [2]. Apoptosis is a conserved
genetic program for the removal of malfunctioning or
potentially dangerous cells. Intestinal epithelial cells undergo
apoptosis when they lose their contact with the extracellular
matrix, a phenomenon termed “anoikis” [3]. This special
form of cell death is likely to be the main mechanism
terminating the physiological life cycle of intestinal epithelial
cells, because they gradually lose cell anchorage on their
march toward the intestinal lumen. Mechanisms terminating
the short physiological life cycle of epithelial cells are
supposed to have an impact on these essential functions and
have inﬂuence on inﬂammatory reactions in the intestinal
mucosa. A disturbance of the epithelial barrier is thought to
be a major factor in the pathogenesis of inﬂammatory bowel
disease.
This review focuses on recent signiﬁcant research ﬁnd-
ings regarding mechanisms of bacteria-induced apoptosis,
probiotic actions which promote host homeostasis, and
the potential relevance of these mechanisms to mucosal
inﬂammation and inﬂammatory bowel disease.2 International Journal of Inﬂammation
2.CellShedding,Sealing,andHealing
The life cycle of a nontransformed, intestinal epithelial cell
is terminated by apoptosis or, if cells lose their contact with
the matrix, by anoikis. The mechanism of cell shedding is
important as abundant shedding must be achieved without
lossofintestinalbarrierfunction.Animpermeablesubstance
plugs epithelial discontinuities on the villus as a reaction to
cell shedding, resulting in 3% of surface area having gaps
near the villus tip [4]. Gaps contain no cellular material
but are ﬁlled with a substance that maintains the epithelial
barrier, despite discontinuities in the cellular layer. The
source and composition of this “plugging” substance is
unknown but could be secreted by neighboring epithelial
cells, myoﬁbroblasts, or the shed epithelial cell itself.
Physical wounding in human tissue culture models
shows activation of myosin light chain kinase leading to
contraction of an actin ring that, like a purse string, closes
oﬀ the denuded region and restores barrier function [5].
Repair mechanisms after cell shedding in human histological
sections have been characterized as similar to wound healing
mechanisms of cultured epithelial monolayers [6]. During
healing, myosin light chain kinase becomes phosphorylated
a tt h ee d g e so fg a p si nn e i g h b o r i n gc e l l s[ 6]. An actin ring at
the apical pole of cells at the edge of the wound contracts like
a purse-string contracture. For 45% of the shedding events,
cytoplasmic extensions from the neighboring cells were
shown to make a continuous structure beneath the shedding
cell but tight junction activity of ZO-1 was only shown in 9%
of the shedding events [4]. ZO-1 activity remains at the basal
pole of gaps in a V-shaped formation. Thus it was mentioned
that tight junctions from neighboring cells can only be
used in a fraction of instances to help reseal the breach in
the epithelial layer [4, 7]. Watson et al. considered that a
number of shed cells do not have an apoptotic morphology
or suﬃcient caspase activation [8]. Cells could be shed as
largely intact or during early events in the apoptotic cascade.
A forceful cell expulsion after loosening of contacts between
neighboring intestinal cells and the basement membrane
simultaneous with the secretion of an extracellular substance
that ﬁlls the void left by the departing cell was mentioned
[8]. Extracellular matrix molecules provide essential survival
signals to epithelial cells via β1-integrins, focal adhesion
kinase, and protein kinase B/Akt-1 pathways [9, 10]. Loss
of cell-cell and cell-matrix contacts causes anoikis [3].
Preservation of cell-cell anchorage after ex vivo isolation
of intestinal epithelial cells maintains survival. Src, PI3-K,
and Akt, as well as the adherens junction protein β-catenin,
are important elements of cell-cell anchorage-mediated anti-
apoptotic signals in intestinal epithelial cells [11]. Apoptotic
deletionofepithelialcellsfromtheintactintestinalmucosais
not accompanied by detectable inﬂammatory response and
little, if any, disruptions of the intestinal epithelial barrier
integrity are not the major route for bacterial translocation.
3. Implications for Disease
Disturbance of the epithelial barrier and epithelial transport
processes is often discussed to be a major factor in the
pathogenesis of intestinal inﬂammation and inﬂammatory
boweldisease.Increasedpermeabilityoftheepithelialbarrier
in ulcerative colitis was ﬁrst reported in 1973 [11]. In a
study by Hagiwara et al., epithelial apoptosis in mucosa from
patients with ulcerative colitis was found to be considerably
upregulated compared with control sigmoid colon [12]. An
apoptotic rate of approximately 27.9% in patients ultimately
requiring surgery for severe and/or steroid-refractory dis-
ease, 17.3% in patients receiving medication alone for more
than 3 years, and 13.1% in patients with infectious colitis
compared to 2.8% in the control colon. Increased perme-
ability of the epithelial barrier in Crohn’s disease was ﬁrst
reported in 1986 [13]. In a study by Zeissig et al., epithelial
apoptosis in mucosa from patients with Crohn’s disease was
foundtobe considerablyupregulatedcomparedwithcontrol
sigmoid colon [14]. An apoptotic rate of approximately
5.3% was obtained in the inﬂamed colon compared to
2.1% in the control colon. The apoptotic rate seems to be
higher in ulcerative colitis than in Crohn’s disease. Direct
comparison of the apoptotic rate seems to be objectionable
because of unequal experimental conditions. Abnormal gut
permeability is characterized by measurably increased rates
of apoptosis among epithelial cells. Intestinal bacteria are
essential for the development of intestinal inﬂammation.
A number of knockout models of inﬂammatory bowel
disease conﬁrm that bacteria are essential for the onset of
inﬂammation [15–17].
4.Cytokine-InducedApoptosis
4.1. TNF Increases Cell Shedding. Apoptosis can be induced
by mucosal factors secreted by epithelial cells. Several studies
have suggested that tumor necrosis factor (TNF) is central
to epithelial injury. The epithelial cell lines T84, HT29, and
Caco-2 secrete the proinﬂammatory cytokines interleukin
(IL)-8, MCP-1, GM-CSF, and TNF after exposure to the
gram-negative invasive bacteria Salmonella dublin, Yersinia
enterocolitica, Shigella dysenteriae, and the gram-positive
invasive bacterium Listeria monocytogenes. Expression of
the same array of cytokines has also been shown in
freshly isolated human colon epithelial cells [18, 19]. The
noninvasive bacteria Escherichia coli DH5α and Enterococcus
faecium had no signiﬁcant eﬀect on secretion [19, 20]. The
cytokine TNF has been found to be elevated in inﬂammatory
bowel disease where epithelial apoptosis is increased [21].
Accordingly, TNF induces both apoptosis and cell shedding
when given to mice [22]. In intact intestinal mucosa, local
barrier function was preserved during physiological cell
shedding but was altered during TNF-induced loss of cells
in mice. Approximately 20% of the TNF-evoked gaps were
found to present no luminal permeability barrier [8]. TNF
substantially increased gap formation and cell loss both indi-
vidually and in sheets of up to 18 cells [23]. Extensive TNF-
mediated apoptosis might be beyond the normal capacity to
sustain gap impermeability. Supportive downregulation of
epithelial apoptosis was found after TNF antibody treatment
in patients with active Crohn’s disease [14, 24] and in mouse
models of colitis [24, 25]. As soon as microbes or theirInternational Journal of Inﬂammation 3
products have passed the epithelial barrier, TNF is also
secreted by activated macrophages and T lymphocytes [26].
Apart from bacteria-induced apoptosis, dysregulated signals
from the intestinal immune system are a major trigger of
intestinalepithelialcellapoptosis.Intestinalmucosalbiopsies
from patients with active Crohn’s disease contain increased
numbers of TNF-secreting cells [27]. However, TNF initiates
both antiapoptotic and proapoptotic signalling through the
distinct receptors TNFR1 and 2 in a concentration [28, 29]
and time- [30] dependent manner.
4.2. Probiotics Decrease TNF-Induced Cell Shedding. Several
probiotics have been shown to prevent cytokine-induced
apoptosis in epithelial cells. Lactobacillus rhamnosus GG
(LGG), a bacterium used in the fabrication of yoghurt,
prevents cytokine-induced apoptosis in mouse or human
intestinal epithelial cells [31]. Studies on the relationship
between LGG and both the murine colon epithelial cell
line YAMC and the human colonic epithelial cell line HT-
29 demonstrated that LGG inhibits TNF-induced apoptosis.
LGG promotes the survival of cells through activation of
the antiapoptotic Akt/protein kinase B in a PI3K-dependent
manner and inhibition of the pro-apoptotic p38/mitogen-
activated protein kinase activated by TNF, IL-1, or IFNγ.
LGG produces soluble factors which can be recovered from
bacterial culture without previous bacterial-intestinal cell
contact [31]. LGG has been shown to reduce chemically
induced intestinal epithelial apoptosis in vitro in IEC-6 and
ex vivo in animal experiments [32]. Two novel proteins have
been identiﬁed in LGGculturesupernatant, p40 and p75; the
ﬁrst probiotic bacterial proteins demonstrated to promote
intestinal epithelial homeostasis through speciﬁc signaling
pathways [33]. These two factors are heat- and protease-
sensitive [34]. Both p75 and p40 rescue TNF-induced
epithelial damage, ulcerative lesions including disruption
of epithelial integrity and epithelial apoptosis in cultured
mouse colon explants. LGG has been shown to induce
remission and prevent recurrence of inﬂammatory bowel
disease in patients [35] as well as in animal models of colitis
[36] but therapy in children with Crohn’s disease showed no
beneﬁcial eﬀect [37].
5. NF-κB Deﬁciency Leads to Apoptosis in
IntestinalEpithelialCells
Bacteria display pathogen-associated molecular patterns
recognized by Toll-like receptors (TLRs) at the surface of
enterocytes required for the initiation of an inﬂammatory
response. Intracellularly MyD88 transduces recognition sig-
nals for all bacteria. Downstream, inactive transcription
factor nuclear factor-kappa B (NF-κB) is complexed with
inhibitory protein IκB. NF-κB is activated by dissociation of
IκB followed by ubiquitination and proteasomal degradation
of the inhibitor. Dissociation of IκB is induced through
phosphorylation of inhibitor by IκB kinase (IKK), a complex
oftwoenzymaticallyactivesubunitsIKKαandIKKβtogether
with the regulatory subunit IKKγ (NEMO) [38]. NF-κBi s
activatedinintestinalepithelialcellsofinﬂamedmucosa[39]
andTNFisoneofseveralprototypicNF-κBtargetgenes[40].
Contrary, physiological importance of TLR-signalling
and NF-κB-activation for intestinal homeostasis and main-
tenance of epithelial barrier has been shown in several
recent studies. Inhibition of NF-κB activation results in
increased caspase activation and apoptosis [41]. TLR2-
, TLR4-, and MyD88-deﬁcient mice exhibited colonic
bleeding [42]. Colons from MyD88-deﬁcient mice showed
severe and extensive denudation of the surface epithelium
[42] but an increased number of proliferating epithelial
cells. Dysregulated proliferation suggests the execution of a
compensatory mechanism of intestinal epithelial cells as part
of the physiological repair response to injury. Also, loss of
TLR5 resulted in spontaneous colitis [43]. IKKγ (NEMO)
deﬁciency in intestinal epithelial cells caused spontaneous
colitis in mice associated with massive epithelial apoptosis,
lost of barrier integrity, and translocation of commensal
bacteria in the colon [44]. Analysis of proinﬂammatory gene
expression showed upregulation of TNF in the colon [44].
A similar inﬂammation phenotype was observed in mice
lacking both IKKα and IKKβ.
There are mixed results implicating NF-κBi nv a r i o u s
models of apoptosis with both pro and antiapoptotic eﬀects
observed [41]. Downregulated expression of NF-κBt a r g e t
genes with pro-survival functions in intestinal epithelial cells
would be expected to exacerbate disease [38]. Completely
absent NF-κB-activation is followed by accelerated epithelial
apoptosis and loss of epithelial barrier associated with
enhanced exposure to bacteria. Inﬂammatory response is the
total of the activation of both pro- and antiinﬂammatory
signaling pathways in host cells.
6. More Probiotics,MoreEpithelial
Cell Survival
Probiotics-mediated cytoprotection is the opposite of apop-
tosis. Uptake of probiotics is a therapeutic approach that
regulates the homeostasis of intestinal epithelial cells by
maintaining cell survival and enhancing barrier function.
These nonpathogenic microorganisms have been used for
the treatment of gastrointestinal diseases, including ulcer-
ative colitis [45, 46] and Crohn’s disease [34, 47]. Pro-
posed mechanisms include bacterial interference, increased
cytoprotection and decreased apoptosis of epithelial cells.
Probiotic bacteria interact with three components of the
gastrointestinaltractincludingcompetingbacteria,intestinal
epithelial cells and mucosal immune cells [31].
6.1. Bacterial Interference: Microbe versus Microbe. Bacte-
rial interference describes the condition in which a bac-
terial strain inhibits colonization by competing strains.
The most plausible eﬀect of bacterial interference is the
antagonistic activity of probiotics against inﬂammation-
and/or apoptosis-releasing pathogens. Probiotics prevent
colonization by other pathogenic bacteria by the production
of growth inhibitors including bacteriocins [48, 49]a n d
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adhesion sites on intestinal epithelial cells thereby replacing
intestinal pathogens [51, 52]. Maintaining the integrity of
intestinal epithelial cells by bacterial interference is espe-
cially relevant during defense against invasive pathogens.
The probiotic Escherichia coli strain Nissle 1917 (EcN) is
already in use for successful treatment of diseases of the
digestive tract since several decades. EcN was demonstrated
to inhibit invasion of S. typhimurium, Y. enterocolitica, S.
ﬂexneri, Lp n e u m o p h i l aand Listeria monocytogenes in vitro
[53]. The antiapoptotic eﬀects found were due to soluble
factors of EcN. Genomic islands encoding putative ﬁtness
factors were suggested as a genetic basis for the dominance
of EcN upon other strains [54]. Fitness factors such as
diﬀerent iron uptake systems, adhesins, proteases [55], and
the production of microcins [50]m a ys u p p o r ts u r v i v a l
and successful colonization of EcN in the human gut and
most likely contribute to its probiotic character. The anti-
invasive mechanism of EcN is not dependent on direct
physical contact to both epithelial cells and invasive bacteria.
By separating EcN from the epithelial cell line with a
porous membrane invasion is also eﬀectively inhibited. The
invasion systems used by bacterial strains blocked by EcN
are diverse. An anti-invasive secreted component of EcN
was postulated that acts on a central process or structure
on the host [53]. A soluble or shed factor from EcN has
been identiﬁed to induce β-defensin 2 in Caco-2, mediated
throughNF-κB-andAP-1-dependentpathways.β-defensin2
has a broad antibiotic spectrum against gram-negative and -
positivebacteria.Itmayreinforcemucosalbarrierbylimiting
bacterial adherence and invasion. In another study, ﬂagellin
has been shown to be a major stimulatory factor of EcN. The
signal is transmitted by TLR5 [56].
6.2. Cytoprotective Eﬀects Are Anti-Apoptotic Eﬀects. Next to
bacterial interference, more direct cytoprotective eﬀects are
described for soluble factors from probiotica. The probiotic
mixture VSL#3 (L. acidophilus, L. bulgaricus, L. Casei, L.
plantarum, S. thermophilus, B. breve, B. infantis, and B.
longum) has been used as an eﬀective treatment in ulcerative
colitis patients [57]. The therapeutic eﬀect of VSL#3 is
reﬂected by increased cytoprotection of epithelial cells.
An early event that occurs immediately after stimulation
with VSL#3-conditioned medium in vitro is the inhibition of
the proteasome [58]. Increase in ubiquitination is restricted
to few proteins suggesting that particular features of the
proteasome function are speciﬁcally inhibited. One of the
proteins protected from proteasomal degradation is IκBα.
VSL#3-conditioned medium inhibits NF-κBa c t i v a t i o nb y
stabilization of IκBα [58]. Diminished NF-κBa c t i v a t i o n
inhibits endogenous immune response genes normally
activated by NF-κB, such as MCP-1. VSL#3-conditioned
mediumconfersadegreeofprotectionagainstoxidantinjury
through its ability to induce the expression of heat shock
proteins (hsps) [58]. Induction of hsps occurs as a late
event 12 hours after stimulation with VSL#3. Cytoprotective
eﬀects of hsps on epithelial cells are well characterized
[59–61]. Hsp25 and 72 are induced by VSL#3 [58, 62].
Hsp25 preserves cytoskeletal and tight junction functions by
binding to actin ﬁlaments and stabilizing F actin [63]. Hsp72
preserves critical cellular proteins and has been shown to
protect epithelial cell lines against oxidant injury [64]a n d
injury by NH2Cl [60].
7. Xenophagy andERStress inIntestinal
EpithelialCells:NovelLinksto
Apoptosis-RelatedDiseaseMechanisms?
Autophagy is a lysosomal degradation pathway that is
essential for both survival and homeostasis [65]. Autophagy
constitutes a stress adaptation pathway that promotes cell
survival but is also considered to initiate a form of pro-
grammed “autophagic” cell death [65]. Autophagy is rapidly
emerging as an important component of the innate immune
response. Mutations in genes aﬀecting the formation of
autophagosomes [66, 67] or mutations in genes aﬀecting
lysosomal clearance of autophagosomes [68] are associated
with increased frequency of apoptosis (reviewed in [65]). If
autophagy is directed against invading microbes, it is termed
xenophagy [69]. Xenophagy may have evolved as one of
the ﬁrst eukaryotic cell-autonomous defense mechanisms
[70, 71].
Physiological states that increase the demand for protein
folding, or stimuli that disrupt the reactions by which
protein fold, create an imbalance between the protein-
folding load and the capacity of the endoplasmic reticulum
(ER), causing unfolded or misfolded proteins to accumulate
in the ER lumen—a condition referred to as ER stress [72].
It was suggested that ER stress mechanisms and autophagic
pathwaysmayinteractwithinintestinal epithelialcellsinvivo
and may be synergistically related to intestinal inﬂammation
[73, 74].
7.1. Xenophagy. Autophagy directed against intracellular
microbes or their products is termed xenophagy [69].
Yet most publications are focused on monocytes [75],
macrophages[76,77],ﬁbroblasts[78,79],andepithelialcells
of nonintestinal origin [80] showing xenophagy-mediated
killing of bacteria. Survival might be the beneﬁt for a cell if
pathogens are eliminated by xenophagy. Pathogens not elim-
inated by xenophagy might initiate apoptosis, sometimes
accompanied by excessive inﬂammation.
During the last 3 years, xenophagy has also been inves-
tigated in intestinal epithelial cells. A number of single
nucleotide polymorphisms (SNPs) showed clear genetic
association with susceptibility to Crohn’s disease [81, 82].
The strong genetic associations between Crohn’s disease and
both the autophagy-stimulatory immunity-related GTPase,
IRGM1, and the autophagy execution gene, ATG16L, suggest
a potential role for autophagy deregulation in the patho-
genesis of Crohn’s disease [65]. Interestingly, autophagy
genes ATG16L1 and IRGM appear to be more speciﬁc for
Crohn’s disease [83] and IRGM risk alleles may predispose
even more speciﬁcally to the ileal form of Crohn’s disease
[84, 85]. Deﬁciency in ATG16L1 had no eﬀect on the
overall morphology of the ileum or colon in mice [86]b u t
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ileal epithelial cells known to secrete antimicrobial peptides
a n dl y s o z y m e .Al a c ko fl y s o z y m ew a sd e t e r m i n e di nt h e
mucus of ATG16L1-deﬁcient mice together with abnormal
Paneth cell morphology. No evidence has been found for
increased epithelial cell death or proliferation. Deletion
of Atg5 in the intestinal epithelium in Atg5ﬂox/ﬂoxvillin-
Cre mice led to Paneth cell and granule abnormalities
similar to those observed in Atg16L1 mice [86], while other
epithelial cells appeared normal. This indicates that, within
the intestinal epithelium, Paneth cells have a unique sensi-
tivity to autophagy gene disruption. Mucosa from patients
homozygous for the ATG16L1 Crohn’s disease risk allele
contained Paneth cells with similar alterations to those in
ATG16L1 deﬁcient mice including cells with disorganized or
diminished granules or cells exhibiting altered cytoplasmic
lysozyme staining. Within the intestinal epithelium, the
dramatic eﬀect of autophagy protein deﬁciency on Paneth
cells indicates that autophagy can contribute to disease
pathogenesis via a highly speciﬁc role within a single cell
lineage. However, involvement of enterocytes has not been
determined so far.
In contrast, xenophagy can indeed act as a cellular
defense pathway against secreted bacterial toxins in an
apoptosis-dependent manner. Xenophagy targets the nonin-
vasive intestinal pathogen Vibrio cholerae. Intestinal epithe-
lial cells are the main target for the exotoxin Vibrio
cholerae cytolysin (VCC). VCC causes extensive vacuolation
in epithelial cells and autophagosome formation [87]. In
several cell lines, including human intestinal CaCo-2 cells
and C2BBe1, VCC-induced vacuoles colocalized with LC3,
a clear sign of autophagosomal response. In contrast, LC3
remained cytosolic upon VCC treatment in Atg5−/− mouse
embryonic ﬁbroblasts. Autophagy is required to improve
cell survival upon VCC intoxication. Both an inhibitor of
autophagy and an inhibitor of autophagosome formation
have been shown to produce a decrease in cell survival in
CaCo-2 cells [87].
Xenophagy deﬁciency associated with a decrease in
cell survival might contribute to a dysregulated immune
response to commensal intestinal bacteria, altered mucosal
barrier function, and defects in bacterial clearance [88, 89].
It will be essential to further determine whether increased
epithelial apoptosis is a pathway induced as a part of
xenophagy in human primary cells with diﬀerent bacterial
strains.
7.2. ER Stress. The cell has evolved highly speciﬁc signaling
pathways, the unfolded protein response (UPR), to deal
with ER stress conditions [90]. If UPR is not suﬃcient,
the cell enters apoptosis [91]. Three UPR pathways have
been described. The PERK/eIF2α pathway is mediated by a
transcription factor called CHOP/GADD153. CHOP forms
heterodimers with C/EBPα to induce transcription of Bim
in various cell types including kidney epithelial cells, mouse
embryonic ﬁbroblasts, thymocytes, a cancer cell line, and a
myeloid progenitor cell line [92]. Bim is a member of the
pro-apoptotic protein family and counteract with the anti-
apoptotic protein Bcl-2 to promote apoptosis. Stress stimuli
trigger Bim translocation to the mitochondrial surface where
it neutralize the anti-apoptotic action of Bcl-2 and induce
the release of cytochrome c which ﬁnally initiates apoptosis.
Bim protein is dephosphorylated by protein phosphatase
2A during ER stress and is thereby rendered resistant
to ubiquitin/proteasome-mediated degradation [92]. Other
UPR transducers are the activating transcription factor 6
(ATF6) and the inositol-requiring enzyme 1 (IRE1) [91, 93].
Two homologous genes encode IRE1, for which there is
a ubiquitously expressed alpha form and a constitutively
expressed beta form restricted to the intestinal epithelium
[94, 95]. IRE1β has been shown to promote resistance to
DSS-induced colitis [96]. The glucose regulated protein-78
(GRP78/BiP) is a central regulator of the concerted cellular
response of the three UPR transducers IRE1α, PERK, and
ATF6. Several factors are required for optimum protein
folding, including ATP, Ca2+, and an oxidizing environment
to allow disulphide-bond formation [97]. As a consequence
of this specialist environment, the ER is highly sensitive to
stresses that perturb cellular energy levels, the redox state, or
Ca2+ concentration. Such stresses reduce the protein folding
capacity of the ER, which results in the accumulation and
aggregation of unfolded proteins [93].
Increased expression level of the ER stress chaperone
grp-78 in colonic epithelial cells is associated with acute
and chronic inﬂammation in inﬂammatory bowel disease.
Puriﬁed human intestinal epithelial cells from patients with
Crohn’s disease and ulcerative colitis revealed increased
expression levels of grp-78 comparing noninﬂamed and
inﬂamed tissues [98]. As sigmoid diverticulitis patients
revealed similar expression levels, grp-78-mediated ER stress
may be part of the inﬂammatory processes rather than
a speciﬁc feature of inﬂammatory bowel disease. The
regulatory cytokine IL-10 was shown to partly inhibit ER
stress responses in intestinal epithelial cells in mice after
colonizationwithE.faecalis[98,99].TLRsplayanimportant
role in the recognition of microbial molecular patterns. It
has been shown that ER stress-mediated epithelial apoptosis
is associated with the expression of TLRs. A majority of
regulated proteins from a comparison between wild-type
mice and TLR2-deﬁcient mice have been shown to be
involved in energy metabolism and stress responses [100].
Under noninﬂamed and inﬂamed conditions, a lack of
TLR-dependent signals leads to the induction of ER stress-
associated mechanisms in primary intestinal epithelial cells
in the large intestine of TLR2 knockout mice.
A number of pathways have been described that induce
apoptosis by ER stress (reviewed elsewhere [91]). Indeed
microbes can also directly aﬀect ER stress pathways. Trier-
ixin, a triene-ansamycin group compound from a culture
broth of Streptomyces sp., has been shown to directly
inhibittranscriptionfactorX-box-bindingprotein1(XBP1)-
activation [101]. XBP1 deﬁciency increases susceptibility to
colitis in the DSS mouse model [73]. XBP1 level has been
shown to be increased in inﬂamed and noninﬂamed colonic
biopsies from patients with Crohn’s disease and ulcerative
colitis. SNPs within the XPB1 gene region are associated
with inﬂammatory bowel disease. Similar to deﬁciency in
ATG16L1 Xbp1−/− intestine was completely devoid of6 International Journal of Inﬂammation
Paneth cells [73]. Increased apoptosis was determined in
Paneth cells from Xbp1 deﬁcient mice but no evidence has
beenfoundforincreasedepithelialcelldeathorproliferation.
8. Conclusion
Induction of apoptosis in pathogenesis remains diﬃcult
to understand. Breakdown of the epithelial barrier play a
part in the disruption of epithelial defenses and further
accelerates mucosal inﬂammation. The potency of intestinal
epithelial cells to identify bacteria through a set of pattern
recognition receptors and adequately respond to infection,
ultimately with apoptosis of the epithelial cell itself, is
not a nonspeciﬁc phenomenon that only reﬂects severity
of inﬂammation. Increased frequency of apoptosis is not
synonymic with exceeded histiocytic phagocytic capacity. If
human colon epithelial cells undergo exaggerated apoptosis
in response to infection with pathogenic bacteria, this may
be well proposed by the host itself to delete infected and
damaged epithelial cells [102]. Execution of apoptosis is
initiated by a proinﬂammatory program and induced either
by immune competent cells or epithelial cells. On the other
hand, apoptosis could be a strategy of microbial pathogens
to escape from the infected and exhausted host cell to invade
deeper mucosal layers for a prolonged bacterial colonization.
Anti-apoptotic eﬀects of probiotics may be due to blockade
of NF-κB activity and hsp induction.
Balance models are typically discussed to explain the
onset of inﬂammation in the mucosal immune system.
Equilibration indeed could be the topic for the mechanisms
mentioned above. It will be important to evaluate the
complex balance between pro- and anti-apoptotic signals
generated by activated transcription factors and cytokines.
ImpactofxenophagyandERstressonthemolecularnetwork
of defence should be analysed in primary intestinal epithelial
cells in the future.
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